{"title":"Usefulness of DXA-based bone strain index in postmenopausal women with type 2 diabetes mellitus","authors":"Gloria Bonaccorsi, Guido Sciavicco, Luca Rinaudo, Andrea Brigato, Giuliana Fiorella, Aldo Carnevale, Fabio Massimo Ulivieri, Carmelo Messina","doi":"10.1007/s11657-024-01411-5","DOIUrl":"10.1007/s11657-024-01411-5","url":null,"abstract":"<div><h3>\u0000 <i>Summary</i>\u0000 </h3><p>Bone Strain Index (BSI) is a new dual-energy x-ray absorptiometry (DXA)-based index. We retrospectively evaluated data from 153 postmenopausal women with a history of type 2 diabetes mellitus (T2DM). Lumbar spine and femoral Bone Strain Index (BSI) were sensitive to skeletal impairment in postmenopausal women suffering from T2DM.</p><h3>Purpose</h3><p>Bone Strain Index (BSI) is a new dual-energy X-ray absorptiometry (DXA)-based measurement. We evaluated the performance of BSI in predicting the presence of fragility fractures in type 2 diabetes mellitus (T2DM) postmenopausal women.</p><h3>Methods</h3><p>We retrospectively evaluated data from a case–control study of 153 postmenopausal women with a history of at least 5 years of T2DM (age from 40 to 90 years). For each subject, we assessed the personal or familiar history of previous fragility fractures and menopause age, and we collected data about bone mineral density (BMD), BSI, and Trabecular Bone Score (TBS) measurements. Statistical analysis was performed having as outcome the history of fragility fractures.</p><h3>Results</h3><p>Out of a total of 153 subjects, <i>n</i> = 22 (14.4%) presented at least one major fragility fracture. A negative correlation was found between lumbar BSI and lumbar BMD (<i>r</i> = − 0.49, <i>p</i> < 0.001) and between total femur BSI and total femur BMD (<i>r</i> = − 0.49, <i>p</i> < 0.001). A negative correlation was found between femoral neck BSI and femoral neck BMD (<i>r</i> = − 0.22, <i>p</i> < 0.001). Most DXA-based variables were individually able to discriminate between fractured and non-fractured subjects (<i>p</i> < 0.05), and lumbar BSI was the index with the most relative difference between the two populations, followed by femoral BSI.</p><h3>Conclusion</h3><p>Lumbar spine and femoral BSI are sensitive to skeletal impairment in postmenopausal women suffering from T2DM. The use of BSI in conjunction with BMD and TBS can improve fracture risk assessment.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11208269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141454897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hajar AbuAlrob, George Ioannidis, Susan Jaglal, Andrew Costa, Lauren E. Grifith, Lehana Thabane, Jonathan D. Adachi, Cathy Cameron, Loretta Hillier, Arthur Lau, Alexandra Papaioannou
{"title":"Hip fracture rate and osteoporosis treatment in Ontario: A population-based retrospective cohort study","authors":"Hajar AbuAlrob, George Ioannidis, Susan Jaglal, Andrew Costa, Lauren E. Grifith, Lehana Thabane, Jonathan D. Adachi, Cathy Cameron, Loretta Hillier, Arthur Lau, Alexandra Papaioannou","doi":"10.1007/s11657-024-01402-6","DOIUrl":"10.1007/s11657-024-01402-6","url":null,"abstract":"<div><h3>\u0000 <i>Summary</i>\u0000 </h3><p>This population-based study analyzes hip fracture and osteoporosis treatment rates among older adults, stratified by place of residence prior to fracture. Hip fracture rates were higher among older adults living in the community and discharged to long-term care (LTC) after fracture, compared to LTC residents and older adults living in the community. Only 23% of LTC residents at high fracture risk received osteoporosis treatment.</p><h3>Purpose</h3><p>This population-based study examines hip fracture rate and osteoporosis management among long-term care (LTC) residents > 65 years of age compared to community-dwelling older adults at the time of fracture and admitted to LTC after fracture, in Ontario, Canada.</p><h3>Methods</h3><p>Healthcare utilization and administrative databases were linked using unique, encoded identifiers from the ICES Data Repository to estimate hip fractures (identified using the Public Health Agency of Canada algorithm and International Classification of Diseases (ICD)-10 codes) and osteoporosis management (pharmacotherapy) among adults > 66 years from April 1, 2014 to March 31, 2018. Sex-specific and age-standardized rates were compared by pre-fracture residency and discharge location (i.e., LTC to LTC, community to LTC, or community to community). Fracture risk was determined using the Fracture Risk Scale (FRS).</p><h3>Results</h3><p>At baseline (2014/15), the overall age-standardized hip fracture rate among LTC residents was 223 per 10,000 person-years (173 per 10,000 females and 157 per 10,000 males), 509 per 10,000 person-years (468 per 10,000 females and 320 per 10,000 males) among the community to LTC cohort, and 31.5 per 10,000 person-years (43.1 per 10,000 females and 25.6 per 10,000 males). During the 5-year observation period, the overall annual average percent change (APC) for hip fracture increased significantly in LTC (AAPC = + 8.6 (95% CI 5.0 to 12.3; <i>p</i> = 0.004) compared to the community to LTC group (AAPC = + 2.5 (95% CI − 3.0 to 8.2; <i>p</i> = 0.248)) and the community-to-community cohort (AAPC − 3.8 (95% CI − 6.7 to − 0.7; <i>p</i> = 030)). However, hip fracture rate remained higher in the community to LTC group over the study period. There were 33,594 LTC residents identified as high risk of fracture (FRS score 4 +), of which 7777 were on treatment (23.3%).</p><h3>Conclusion</h3><p>Overall, hip fracture rates have increased in LTC and among community-dwelling adults admitted to LTC after fracture. However, hip fracture rates among community-dwelling adults have decreased over time. A non-significant increase in osteoporosis treatment rates was observed among LTC residents at high risk of fracture (FRS4 +). Residents in LTC are at very high risk for fracture and require individualized based on goals of care and life expectancy.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11199290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141449500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Laura Carbone, Petra Bůžková, John A. Robbins, Howard A. Fink, Joshua I. Barzilay, Rachel E. Elam, Carlos Isales
{"title":"Association of serum levels of phenylalanine and tyrosine with hip fractures and frailty in older adults: The cardiovascular health study","authors":"Laura Carbone, Petra Bůžková, John A. Robbins, Howard A. Fink, Joshua I. Barzilay, Rachel E. Elam, Carlos Isales","doi":"10.1007/s11657-024-01408-0","DOIUrl":"10.1007/s11657-024-01408-0","url":null,"abstract":"<div><h3>\u0000 <i>Summary</i>\u0000 </h3><p>This study examined if the amino acids phenylalanine or tyrosine contribute to risk of hip fracture or frailty in older adults. We determined that neither phenylalanine nor tyrosine are important predictors of hip fracture or frailty. We suggest advice on protein intake for skeletal health consider specific amino acid composition.</p><h3>Purpose</h3><p>Protein is essential for skeletal health, but the specific amino acid compositions of protein may have differential associations with fracture risk. The aim of this study was to determine the association of serum levels of the aromatic amino acids phenylalanine and tyrosine with risk for incident hip fractures over twelve years of follow-up and cross sectional associations with frailty.</p><h3>Methods</h3><p>We included 131 older men and women from the Cardiovascular Health Study (CHS) who sustained a hip fracture over twelve years of follow-up and 131 men and women without an incident hip fracture over this same period of time. 42% of this cohort were men and 95% were Caucasian. Weighted multivariable Cox hazards molecules were used to estimate the hazard ratios (HR) and 95% confidence intervals (CI) of incident hip fracture associated with a one standard deviation (SD) higher serum level of phenylalanine or tyrosine. Relative risk regression was used to determine the cross-sectional association of these amino acids with Freid’s frailty index.</p><h3>Results</h3><p>Neither serum levels of phenylalanine (HR 0.85 (95% CI 0.62–1.16) or tyrosine (HR 0.82 (95% CI 0.62–1.1) were significantly associated with incident hip fractures or cross sectionally with frailty (frail compared with prefrail/not frail) (HR 0.92 (95% CI 0.48–1.76) and HR (0.86 (95% CI 0.46–1.61) respectively.</p><h3>Conclusion</h3><p>Phenylalanine and tyrosine are not significant contributors to hip fractures or frailty in older men and women.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141426122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Juan Felipe Betancur, Luz Eugenia Pérez, Jhon Edwar Bolaños-López, Verónica Bernal
{"title":"High and very high risk of osteoporotic fracture in Colombia, 2003–2022: identifying diagnostic and treatment gaps","authors":"Juan Felipe Betancur, Luz Eugenia Pérez, Jhon Edwar Bolaños-López, Verónica Bernal","doi":"10.1007/s11657-024-01409-z","DOIUrl":"10.1007/s11657-024-01409-z","url":null,"abstract":"<div><h3>Summary</h3><p>This study examined the clinical characteristics and refracture rates of Colombian patients with high- and very high-risk osteoporosis. This reveals osteoporosis diagnoses and treatment gaps. Only 5.3% of the patients were diagnosed with osteoporosis at discharge and 70.5% had refractures. This finding underscores the need for national policies to enhance osteoporosis prevention and treatment.</p><h3>Purpose</h3><p>This study aimed to assess the clinical features and refracture rates among patients with high- and very-high-risk osteoporosis in Colombia, highlighting diagnostic and treatment gaps.</p><h3>Methods</h3><p>A retrospective observational study was conducted using the medical records of patients aged ≥ 50 years who experienced fragility fractures between 2003 and 2022. Clinical and demographic characteristics at the time of the initial fracture were analyzed, as well as the subsequent imminent risk (refracture rate) and the diagnosis and treatment gap.</p><h3>Results</h3><p>303.982 fragility fractures occurred, and only 5.3% of patients were diagnosed with osteoporosis upon discharge. The most prevalent index fractures were forearm, vertebral, rib, and hip. Only 17.8% of the cohort had a matched osteoporosis diagnosis, indicating a low healthcare capture. Among the diagnosed patients, 10.08% were classified as high- and very high-risk of fracture, predominantly women with a mean age of 73 years. Comorbidities included diabetes, Sjögren’s syndrome, and heart failure. The prevalence of osteoporosis has increased significantly from 2004 to 2022, possibly due to improved detection methods, an aging population, or a combination of both. Despite this increase, treatment delay was evident. Refractures affected 70.5% of the patients, with forearm, hip, humerus, and vertebral fractures being the most common, with a mean time of refracture of 7 months.</p><h3>Conclusion</h3><p>Significant delays were observed in the diagnosis and treatment of fragility fractures. Colombia’s government and health system must address osteoporosis by implementing national policies that prioritize osteoporosis and fragility fracture prevention and reduce delays in diagnosis and treatment.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141426124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Laurna Bullock, Fay Manning, Ashley Hawarden, Jane Fleming, Sarah Leyland, Emma M. Clark, Simon Thomas, Christopher Gidlow, Cynthia P. Iglesias-Urrutia, Joanne Protheroe, Janet Lefroy, Sarah Ryan, Terence W. O’Neill, Christian Mallen, Clare Jinks, Zoe Paskins
{"title":"Exploring practice and perspectives on shared decision-making about osteoporosis medicines in Fracture Liaison Services: the iFraP development qualitative study","authors":"Laurna Bullock, Fay Manning, Ashley Hawarden, Jane Fleming, Sarah Leyland, Emma M. Clark, Simon Thomas, Christopher Gidlow, Cynthia P. Iglesias-Urrutia, Joanne Protheroe, Janet Lefroy, Sarah Ryan, Terence W. O’Neill, Christian Mallen, Clare Jinks, Zoe Paskins","doi":"10.1007/s11657-024-01410-6","DOIUrl":"10.1007/s11657-024-01410-6","url":null,"abstract":"<div><h3>Summary</h3><p>Interviews and focus groups with patients, FLS clinicians, and GPs identified challenges relating to clinical and shared decision-making about bone health and osteoporosis medicines. Findings will inform the development of the multicomponent iFraP intervention to address identified training needs and barriers to implementation to facilitate SDM about osteoporosis medicines.</p><h3>Purpose</h3><p>The iFraP (improving uptake of Fracture Prevention treatments) study aimed to develop a multicomponent intervention, including an osteoporosis decision support tool (DST), to support shared decision-making (SDM) about osteoporosis medicines. To inform iFraP intervention development, this qualitative study explored current practice in relation to communication about bone health and osteoporosis medicines, anticipated barriers to, and facilitators of, an osteoporosis DST, and perceived training needs.</p><h3>Methods</h3><p>Patients attending an FLS consultation (<i>n</i> = 8), FLS clinicians (<i>n</i> = 9), and general practitioners (GPs; <i>n</i> = 7) were purposively sampled to participate in a focus group and/or telephone interview. Data were transcribed, inductively coded, and then mapped to the Theoretical Domains Framework (TDF) as a deductive framework to systematically identify possible barriers to, and facilitators of, implementing a DST.</p><h3>Results</h3><p>Inductive codes were deductively mapped to 12 TDF domains. FLS clinicians were perceived to have specialist expertise (knowledge). However, clinicians described aspects of clinical decision-making and risk communication as difficult (cognitive skills). Patients reflected on decisional uncertainty about medicines (decision processes). Discussions about current practice and the proposed DST indicated opportunities to facilitate SDM, if identified training needs are met. Potential individual and system-level barriers to implementation were identified, such as differences in FLS configuration and a move to remote consulting (environmental context and resources).</p><h3>Conclusions</h3><p>Understanding of current practice revealed unmet training needs, indicating that using a DST in isolation would be unlikely to produce a sustained shift to SDM. Findings will shape iFraP intervention development to address unmet needs.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11186902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141426123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nur Khadijah Muhamad Jamil, Isa Naina Mohamed, Sabarul Afian Mokhtar, Juzaily Fekry Leong, Nur Azree Ferdaus Kamudin, Norliza Muhammad
{"title":"Barriers to osteoporosis management and adherence to Clinical Practice Guideline: a comparative study between tertiary East Coast hospitals and a Fracture Liaison Services (FLS)-accredited hospital in Malaysia","authors":"Nur Khadijah Muhamad Jamil, Isa Naina Mohamed, Sabarul Afian Mokhtar, Juzaily Fekry Leong, Nur Azree Ferdaus Kamudin, Norliza Muhammad","doi":"10.1007/s11657-024-01407-1","DOIUrl":"10.1007/s11657-024-01407-1","url":null,"abstract":"<div><h3>Summary</h3><p>This study compares osteoporosis management between tertiary East Coast hospitals and a FLS-accredited hospital in Malaysia. It identifies significant barriers and highlights the superior performance of FLS in areas like timely treatment initiation and treatment monitoring. The insights are crucial for improving osteoporosis management strategies.</p><h3>Introduction</h3><p>Osteoporosis management poses a substantial healthcare challenge, necessitating effective strategies and Clinical Practice Guidelines (CPG) adherence.</p><h3>Methods</h3><p>The study employed a self-administered online questionnaire via Google Forms. Orthopedic clinicians from all study sites were invited to participate via messaging platforms. A total of 135 participants completed the questionnaire and the data was proceeded to statistical analyses.</p><h3>Results</h3><p>The study identified significant barriers, including inadequate knowledge of current osteoporosis guidelines and medications (<i>p</i> = 0.014), limited choice of anti-osteoporosis medication (<i>p</i> < 0.001), insufficient post-fracture care staff (<i>p</i> < 0.001), patients’ financial constraints due to socioeconomic status (<i>p</i> = 0.027), and lack of doctor-patient time (<i>p</i> = 0.042). FLS demonstrated superior performance in CPG adherence in areas such as clinical diagnosis of osteoporosis without BMD assessment (<i>p</i> = 0.046), timely treatment initiation (<i>p</i> < 0.001), treatment monitoring using BMD (<i>p</i> = 0.004), reassessment treatment after 3–5 years of bisphosphonate therapy (<i>p</i> = 0.034) and considering anabolic agents in very high-risk patients (<i>p</i> = 0.018).</p><h3>Conclusion</h3><p>The findings highlight an essential opportunity for improvement and emphasize the necessity for robust strategies and strict adherence to Clinical Practice Guidelines (CPG), especially within tertiary East Coast hospitals. The exemplary efficacy demonstrated by the FLS model strongly advocates for its broader integration across multiple hospitals, promising substantial advancements in osteoporotic patient care outcomes throughout Malaysia.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Chandran, N. Aftab, A. Amin, T. Amphansap, S. K. Bhadada, M. Chadha, D. C. Chan, F. L. Hew, S. Kaur, A. H. Khan, A. K. Kwee, L. T. Ho-Pham, S. Lekamwasam, D. C. Minh, A. Prasanth, R. Sharma, T. Valleenukul, N. Zehra, A. Mithal
{"title":"Evaluating compliance with the care standard of proactively assessing bone health in patients with diabetes: a pilot audit of practice across Asia by the Asia Pacific Consortium on Osteoporosis (APCO)","authors":"M. Chandran, N. Aftab, A. Amin, T. Amphansap, S. K. Bhadada, M. Chadha, D. C. Chan, F. L. Hew, S. Kaur, A. H. Khan, A. K. Kwee, L. T. Ho-Pham, S. Lekamwasam, D. C. Minh, A. Prasanth, R. Sharma, T. Valleenukul, N. Zehra, A. Mithal","doi":"10.1007/s11657-024-01399-y","DOIUrl":"10.1007/s11657-024-01399-y","url":null,"abstract":"<div><h3>Summary</h3><p>This pilot audit explored how bone health is assessed patients with diabetes in diverse centres across Asia. Only 343 of 1092 (31%) audited patients had a bone health assessment, 27% of whom were diagnosed with osteoporosis. Quality improvement strategies are needed to address gaps in patient care in this area.</p><h3>Purpose</h3><p>The Asia Pacific Consortium on Osteoporosis (APCO) Framework outlines clinical standards for assessing and managing osteoporosis. A pilot audit evaluated adherence to clinical standard 4, which states that bone health should be assessed in patients with conditions associated with bone loss and/or increased fracture risk; this report summarises the audit findings in patients with diabetes. A secondary aim was to assess the practicality and real-world use of the APCO bone health audit tool kit.</p><h3>Methods</h3><p>Eight centres across Asia participated in the pilot audit, selecting diabetes as the target group. Participants reviewed their practice records for at least 20 consecutively treated patients with the target condition. Questions covered routine investigations, bone health assessment, osteoporosis diagnosis, and patient referral pathways. Data were summarised descriptively.</p><h3>Results</h3><p>The participants represented public hospitals, university medical centres, and private clinics from India, Malaysia, Pakistan, Singapore, Taiwan, and Vietnam that see an estimated total of 95,000 patients with diabetes per year. Overall, only 343 of 1092 audited patients (31%) had a bone health assessment. Osteoporosis was subsequently diagnosed in 92 of 343 (27%) patients.</p><h3>Conclusion</h3><p>Bone health was not assessed in most patients with diabetes. The results provide insight into current practices across diverse Asian centres and demonstrate the practical value of the audit tool kit. Participant feedback has been used to improve the tool kit. Results of this pilot audit are being used in the respective centres to inform quality improvement projects needed to overcome the gap in patient care.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11166814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cristina Comeras-Chueca, Lorena Villalba-Heredia, Gabriel Lozano-Berges, Ángel Matute-Llorente, Jorge Marín-Puyalto, Germán Vicente-Rodríguez, José A. Casajús, Alejandro González-Agüero
{"title":"High muscular fitness level may positively affect bone strength and body composition in children with overweight and obesity","authors":"Cristina Comeras-Chueca, Lorena Villalba-Heredia, Gabriel Lozano-Berges, Ángel Matute-Llorente, Jorge Marín-Puyalto, Germán Vicente-Rodríguez, José A. Casajús, Alejandro González-Agüero","doi":"10.1007/s11657-024-01405-3","DOIUrl":"10.1007/s11657-024-01405-3","url":null,"abstract":"<div><h3>Summary</h3><p>Muscular fitness plays a major role in bone health and body composition in overweight and obese children. It is key that the development of this muscle fitness is affected by absolute isometric strength and dynamic strength.</p><h3>Purpose</h3><p>To compare bone health and body composition between overweight/obese children considering muscular fitness (MF) levels, and to investigate whether weight-bearing dynamic or absolute isometric strength, both involved in the development of this muscular fitness, are more related with bone health.</p><h3>Methods</h3><p>MF of 59 overweight or obese children (10.1 ± 0.9 years, 27 females) was measured by a countermovement jump (CMJ), handgrip, and maximal isometric strength of knee extension. Participants were divided into four groups depending on their MF level performing a cluster analysis: 16 children with high MF (HMF) in all tests, 18 with high performance in isometric strength (HIS), 15 with high performance in CMJ (HCMJ) and 10 low isometric and low dynamic force values (LMF). Body composition values were measured by dual energy X-ray absorptiometry, and bone strength values were assessed by peripheral quantitative computed tomography. Motor skills were evaluated using TGMD-3. Multivariate analysis of covariance test was applied to analyse bone strength differences between children in the different MF groups, using maturity offset, height and weight as covariates, and correlations were investigated.</p><h3>Results</h3><p>HMF excelled in bone health. HIS had higher cortical bone area, periosteal circumference, bone mass, polar strength strain index and fracture load than LMF, while HCMJ only showed better results in trabecular bone area than LMF. HMF had significantly better values of fracture load and periosteal and endosteal circumferences than HCMJ, but not than HIS.</p><h3>Conclusions</h3><p>High MF level shows positive effects on bone health in overweight/obese children. Those with highest isometric strength had better bone health compared to those with higher dynamic strength.</p><h3>Trial registration</h3><p>The research project was registered in a public database Clinicaltrials.gov in June 2020 with the identification number NCT04418713.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11164759/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141295474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oscar Gómez, Claudia Campusano, Sonia Cerdas-P, Beatriz Mendoza, Amanda Páez-Talero, María Pilar de la Peña-Rodríguez, Alfredo Adolfo Reza-Albarrán, Pedro Nel Rueda-Plata
{"title":"Clinical Practice Guidelines of the Latin American Federation of Endocrinology for the use of vitamin D in the maintenance of bone health: recommendations for the Latin American context.","authors":"Oscar Gómez, Claudia Campusano, Sonia Cerdas-P, Beatriz Mendoza, Amanda Páez-Talero, María Pilar de la Peña-Rodríguez, Alfredo Adolfo Reza-Albarrán, Pedro Nel Rueda-Plata","doi":"10.1007/s11657-024-01398-z","DOIUrl":"10.1007/s11657-024-01398-z","url":null,"abstract":"<p><strong>Introduction: </strong>These guidelines aim to provide evidence-based recommendations for the supplementation of Vitamin D in maintaining bone health. An unmet need persists in Latin American regarding the availability of clinical and real-world data for rationalizing the use of vitamin D supplementation. The objective of these guidelines is to establish clear and practical recommendations for healthcare practitioners from Latin American countries to address Vitamin D insufficiency in clinical practice.</p><p><strong>Methods: </strong>The guidelines were developed according to the GRADE-ADOLOPMENT methodology for the adaptation or adoption of CPGs or evidence-based recommendations. A search for high quality CPGs was complemented through a comprehensive review of recent literature, including randomized controlled trials, observational studies, and systematic reviews evaluating the effects of Vitamin D supplementation on bone health. The evidence to decision framework proposed by the GRADE Working Group was implemented by a panel of experts in endocrinology, bone health, and clinical research.</p><p><strong>Results: </strong>The guidelines recommend Vitamin D supplementation for individuals aged 18 and above, considering various populations, including healthy adults, individuals with osteopenia, osteoporosis patients, and institutionalized older adults. These recommendations offer dosing regimens depending on an individualized treatment plan, and monitoring intervals of serum 25-hydroxyvitamin D levels and adjustments based on individual results.</p><p><strong>Discussion: </strong>The guidelines highlight the role of Vitamin D in bone health and propose a standardized approach for healthcare practitioners to address Vitamin D insufficiency across Latin America. The panel underscored the necessity for generating local data and stressed the importance of considering regional geography, social dynamics, and cultural specificities when implementing these guidelines.</p>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gianpaolo Voltan, Gennaro Di Giovannantonio, Giovanni Carretta, Stefano Vianello, Cristina Contessa, Nicola Veronese, Maria Luisa Brandi
{"title":"A novel case-finding strategy based on artificial intelligence for the systematic identification and management of individuals with osteoporosis or at varying risk of fragility fracture.","authors":"Gianpaolo Voltan, Gennaro Di Giovannantonio, Giovanni Carretta, Stefano Vianello, Cristina Contessa, Nicola Veronese, Maria Luisa Brandi","doi":"10.1007/s11657-024-01403-5","DOIUrl":"https://doi.org/10.1007/s11657-024-01403-5","url":null,"abstract":"<p><p>An artificial intelligence-based case-finding strategy has been developed to systematically identify individuals with osteoporosis or at varying risk of fragility fracture. This strategy has the potential to close the critical care gap in osteoporosis treatment in primary care, thereby lessening the societal burden imposed by fragility fractures.</p><p><strong>Background: </strong>Osteoporotic fractures represent a major cause of morbidity and, in older adults, a precursor of disability, loss of independence, poor quality of life and premature death. Despite the detrimental health impact, osteoporosis remains largely underdiagnosed and undertreated worldwide. Subjects at risk for osteoporosis-related fractures are identified either via organised screening or case finding. In the absence of a population-based screening policy, subjects at high risk of fragility fractures are opportunistically identified when a fracture occurs or because of other clinical risk factors (CRFs) for osteoporotic fracture and areal bone mineral density (aBMD) measured by dual-energy X-ray absorptiometry (DXA).</p><p><strong>Purpose: </strong>This paper describes the development of a novel case-finding strategy, named Osteoporosis Diagnostic and Therapeutic Pathway (ODTP), which enables to identify subjects with osteoporosis or at varying risk of fragility fracture. This strategy is based on a specifically designed software tool, named \"Bone Fragility Query\" (BFQ), which analyses the electronic health record (EHR) databases of General Practitioners (GPs) to systematically identify individuals who should be prescribed DXA-BMD measurement, vertebral fracture assessment (VFA) and anti-osteoporosis medications (AOM).</p><p><strong>Conclusions: </strong>The ODTP through BFQ tool is a feasible, convenient and time-saving osteoporosis model of care for GPs during routine clinical practice. It enables GPs to shift their focus from what to do (clinical guidelines) to how to do it in the primary health care setting. It also allows a systematic approach to primary and secondary prevention of fragility fractures, thereby overcoming clinical inertia and contributing to closing the gap between evidence and practice for the management of osteoporosis in primary care.</p>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141178933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}